Lv729
5000 积分 2023-12-06 加入
Degrader-Drug Conjugate (DDC) Mediated Immunochemotherapy for Tumor Treatment
1个月前
已完结
Design, Synthesis, and Antitumor Activity Evaluation of 2-Arylmethoxy-4-(2,2′-dihalogen-substituted biphenyl-3-ylmethoxy) Benzylamine Derivatives as Potent PD-1/PD-L1 Inhibitors
2个月前
已完结
Design, synthesis, anti-tumor activity and mechanism of novel PROTACs as degraders of PD-L1 and inhibitors of PD-1/PD-L1 interaction
2个月前
已完结
Prodrug Strategy for PROTACs: High Efficiency and Low Toxicity
2个月前
已完结
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2个月前
已完结
Camouflaging Nanoparticles with Brain Metastatic Tumor Cell Membranes: A New Strategy to Traverse Blood–Brain Barrier for Imaging and Therapy of Brain Tumors
3个月前
已完结
Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease
3个月前
已完结
Rational Design of PROTAC Degraders and Their Spatiotemporal Controlled Delivery for Enhanced Tumor Penetration and PD-L1 Protein Degradation
3个月前
已完结
Rational Design of PROTAC Degraders and Their Spatiotemporal Controlled Delivery for Enhanced Tumor Penetration and PD-L1 Protein Degradation
3个月前
已完结
Discovery of a Novel Covalent EZH2 Inhibitor Based on Tazemetostat Scaffold for the Treatment of Ovarian Cancer
3个月前
已完结
皖公网安备34019202002308
